Meadow Creek Investment Management’s Cantel Medical Corporation CMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q3
$226K Sell
3,024
-880
-23% -$74.6K ﹤0.01% 1001
2019
Q2
$315K Buy
3,904
+256
+7% +$18K 0.01% 881
2019
Q1
$244K Buy
3,648
+624
+21% +$47.3K 0.01% 946
2018
Q4
$225K Hold
3,024
0.01% 923
2018
Q3
$278K Buy
3,024
+656
+28% +$62.5K 0.01% 963
2018
Q2
$233K Hold
2,368
﹤0.01% 946
2018
Q1
$264K Hold
2,368
0.01% 893
2017
Q4
$244K Buy
2,368
+416
+21% +$41.4K 0.01% 924
2017
Q3
$184K Buy
1,952
+272
+16% +$21.5K ﹤0.01% 948
2017
Q2
$131K Buy
1,680
+704
+72% +$52.9K ﹤0.01% 1014
2017
Q1
$78K Sell
976
-32
-3% -$2.54K ﹤0.01% 1026
2016
Q4
$79K Buy
+1,008
New +$78.3K ﹤0.01% 996

Other funds holding CMD

Meadow Creek Investment Management's CMD Position: Q3 2019 in Review

Meadow Creek Investment Management reduced its Cantel Medical Corporation (CMD) stake by 23% in Q3 2019, selling an estimated $74.6K and leaving 3,024 shares worth $226K. The position accounts for ﹤0.01% of the portfolio, ranked #1001.

Meadow Creek Investment Management first reported a position in CMD in Q4 2016 and has held it in 12 quarters since. The position peaked at $315K in Q2 2019. 244 funds tracked by Wall St. Rank hold CMD as of Q3 2019.

  • Meadow Creek Investment Management held 3,024 shares of Cantel Medical Corporation worth $226K as of Q3 2019.
  • Meadow Creek Investment Management sold 880 Cantel Medical Corporation shares in Q3 2019, an estimated $74.6K.
  • Cantel Medical Corporation made up ﹤0.01% of Meadow Creek Investment Management's portfolio in Q3 2019, its #1001 holding.
  • Meadow Creek Investment Management first reported a position in Cantel Medical Corporation in Q4 2016 and has held it in 12 quarters since.
  • Meadow Creek Investment Management's Cantel Medical Corporation position peaked at $315K in Q2 2019.
  • 244 funds tracked by Wall St. Rank held Cantel Medical Corporation as of Q3 2019.

Based on Meadow Creek Investment Management's 13F filing for Q3 2019, filed 14 Nov 2019.